Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13,005Revenue $M7,144Net Margin (%)-56.1Z-Score-0.4
Enterprise Value $M16,991EPS $-3.3Operating Margin %-53.4F-Score4
P/E(ttm))0Cash Flow Per Share $1.5Pre-tax Margin (%)-56.7Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %0Quick Ratio1.2Cash flow > EarningsY
Price/Sales1.95-y EBITDA Growth Rate %0Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow3.8y-y EBITDA Growth Rate %-362.6ROA % (ttm)-23.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-59.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M1,357ROI % (ttm)6.0Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXLeon Cooperman 2013-03-31 Add0.24%$5.73 - $7.81
($7.12)
$ 9.5434%Add 13.43%16,473,300
BSXRay Dalio 2013-03-31 Sold Out $5.73 - $7.81
($7.12)
$ 9.5434%Sold Out0
BSXJoel Greenblatt 2013-03-31 Reduce-0.01%$5.73 - $7.81
($7.12)
$ 9.5434%Reduce -20.11%124,980
BSXMichael Price 2012-12-31 Add0.16%$5.07 - $5.82
($5.49)
$ 9.5474%Add 13.33%1,700,000
BSXMario Gabelli 2012-12-31 Add0.02%$5.07 - $5.82
($5.49)
$ 9.5474%Add 20.63%2,418,305
BSXRay Dalio 2012-12-31 Reduce$5.07 - $5.82
($5.49)
$ 9.5474%Reduce -22.61%42,784
BSXMichael Price 2012-09-30 Add0.78%$4.99 - $5.82
($5.52)
$ 9.5473%Add 149.46%1,500,000
BSXLeon Cooperman 2012-09-30 Add0.31%$4.99 - $5.82
($5.52)
$ 9.5473%Add 24.03%14,331,900
BSXJoel Greenblatt 2012-09-30 Add0.01%$4.99 - $5.82
($5.52)
$ 9.5473%Add 23.88%135,038
BSXMichael Price 2012-06-30 Add0.29%$5.51 - $6.25
($5.89)
$ 9.5462%Add 140.52%601,300
BSXJoel Greenblatt 2012-06-30 Add0.04%$5.51 - $6.25
($5.89)
$ 9.5462%Add 971.66%109,009
BSXRay Dalio 2012-06-30 Buy $5.51 - $6.25
($5.89)
$ 9.5462%New holding, 48184 sh.48,184
BSXLeon Cooperman 2012-06-30 Reduce-0.65%$5.51 - $6.25
($5.89)
$ 9.5462%Reduce -32.67%11,554,900
BSXVanguard Health Care Fund 2012-03-31 Add0.29%$5.3 - $6.36
($5.46)
$ 9.5475%Add 28.93%46,800,000
BSXMichael Price 2012-03-31 Buy 0.21%$5.3 - $6.36
($5.46)
$ 9.5475%New holding, 250000 sh.250,000
BSXJoel Greenblatt 2012-03-31 Buy 0.01%$5.3 - $6.36
($5.46)
$ 9.5475%New holding, 10172 sh.10,172
BSXRay Dalio 2012-03-31 Sold Out -0.18%$5.3 - $6.36
($5.46)
$ 9.5475%Sold Out0
BSXVanguard Health Care Fund 2011-12-31 Add0.27%$5.09 - $5.9
($5.52)
$ 9.5473%Add 37.5%36,300,000
BSXRay Dalio 2011-12-31 Add0.12%$5.09 - $5.9
($5.52)
$ 9.5473%Add 224.01%1,956,684
BSXLeon Cooperman 2011-09-30 Add1.36%$5.62 - $7.28
($6.59)
$ 9.5445%Add 86.1%16,725,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BSX Mario Gabelli 2013-03-312,768,0050.20.14+14.46%
BSX Leon Cooperman 2013-03-3116,473,3001.212+13.43%
BSX Michael Price 2013-03-311,700,0000.131.7
BSX Dodge & Cox 2013-03-3195,996,8237.070.92-1.58%
BSX Vanguard Health Care Fund 2013-03-3145,385,2003.341.4-2.61%
BSX PRIMECAP Management 2013-03-3149,253,6193.630.57-4.01%
BSX Charles Brandes 2013-03-3116,909,8161.251.6-10.46%
BSX Joel Greenblatt 2013-03-31124,9800.010.05-20.11%
BSX Ray Dalio 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pritchard, IanSenior Officer 2013-05-31Buy228,990$0.591516.95view
Mirviss Jeffrey B.SVP&Pres, Periph Intervent 2013-05-31Sell10,941$9.371.81view
Carruthers WendySVP, Human Resources 2013-05-30Sell25,001$9.164.15view
Eaton, Mark PriceDirector, Senior Officer 2013-05-30Buy2,000$0.551634.55view
Connors Nelda JDirector 2013-05-29Sell24,116$9.174.03view
Pritchard, IanSenior Officer 2013-05-21Buy8,000$0.521734.62view
Pritchard, IanSenior Officer 2013-05-17Buy3,500$0.51808view
Hoffman, MichaelSenior Officer 2013-05-16Buy100,000$0.452020view
Eaton, Mark PriceDirector, Senior Officer 2013-05-16Buy125,500$0.471929.79view
Eaton, Mark PriceDirector, Senior Officer 2013-05-15Buy300,000$0.511770.59view

Press Releases about BSX :

Quarterly/Annual Reports about BSX:

News about BSX:

Articles On GuruFocus.com
comment on BSX May 22 2013 
BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector May 14 2013 
Three Key Forces That Drive up Stock Prices Mar 25 2013 
comment on BSX Feb 03 2013 
Why Cooperman and Price Are Betting on Boston Scientific’s Turnaround Dec 31 2012 
Boston Scientific's September Earnings Reflect Aggressive Accounting Oct 24 2012 
comment on BSX Sep 20 2012 
Boston Scientific's Interesting Expenses Sep 11 2012 
Weekly Top Insider Buys: WMB, ADM, VNO, FITB, BSX Aug 13 2012 
Weekly Top Insider Buys: GE, FDX, ADM, BSX, TKR Aug 06 2012 

More From Our Partners
BSX Commences U.S. INTREPID Trial - Analyst Blog Jun 18 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK